News summary

Cleared blood p-tau217 tests matched CSF for amyloid in 514 patients

Source: Longevity Docs News • Published: 20 Nov 2026, 00:00

Summarized by Masters of Longevity from Longevity Docs News.

Plasma p-tau217 matched CSF tests for PET amyloid detection.

Cleared blood p-tau217 tests matched CSF for amyloid in 514 patients
Key Takeaways
  • Lumipulse p-tau217 showed 90%–97% accuracy against PET.
  • Plasma performance was similar to authorized CSF tests.
  • All 514 had cognitive symptoms, so screening utility is unproven.
Read the full article at Longevity Docs News ↗

Continue exploring

Recommended MoL Picks

MoL PickPlan Your Health Tests in Three MinutesThe free Personal Health Diagnostics Planner turns a short questionnaire into a ranked, personalised PDF: a clearer starting point for deciding which health checks deserve attention now.MoL PickBiotin for Hair Growth: The Weak Evidence—and the Blood-Test Risk Most People MissBiotin deficiency can affect hair. That does not mean more biotin makes healthy hair grow—and high doses can distort important laboratory results.MoL PickReducing Inflammation from Ageing Cells: What a Mouse Study FoundResearchers reduced the inflammatory signals released by cells that had stopped dividing. Older mice also improved on some strength and frailty tests. Whether this approach could help people remains unknown.